Contributor Page
Reed Smith
Email  |  Website  |  Articles
Contact Details
Tel: +1 412 2883131
Fax: +1 412 2883063
Reed Smith Centre, 225 Fifth Avenue
PA 15222
United States
By Peter Stuhldreher, Cheryl L Blount
On November 8, 2018, the U.S. Department of Labor (DOL) re-issued an opinion letter rescinding the "80/20 Rule," which prohibited employers from taking a tip credit if a tipped employee spent more than 20% of his or her working time on non-tipped work.
By David Smith, Jason Gordon
Vegan cookie company, Lenny & Larry's Inc., has reached a $5 million settlement with a proposed class of consumers ...
By James Beck
We've blogged several times about the Biomaterials Access Assurance Act of 1998, 21 U.S.C. §§1601-06.
By Jennifer Achilles, Vincent James (Jim) Barbuto
In recent months, the U.S. Securities and Exchange Commission ("SEC") has emphasized cybersecurity as both an enforcement priority and corporate responsibility, demonstrating its continued focus...
By C. Neil Gray, Le-el Sinai
On November 8, 2018, the U.S. Securities and Exchange Commission (the "SEC") settled its first case against an unregistered cryptocurrency exchange.
By Douglas Wood, Keri Bruce, Steven Miller
The Association of National Advertisers (ANA) and Reed Smith released a white paper – Media Buying 2018: Transparency at a Crossroads – reporting on the state of transparency in the advertising...
By Debra McCurdy
The Trump Administration is considering a controversial plan, the International Pricing Index (IPI) model, which would tie Medicare PartB prescription drug payment rates to amounts paid for such drugs
By Rachel B. Weil
Kudos to the multi–firm defense counsel team that brought home the decision on which we report today, a victory that may well end up on our "best" list for 2018.
By David Weiss, T. Connor O'Carroll
Sombrero then set its sights on CES's insurer.
By Andrew Levad, Jason Gordon
The First Circuit recently affirmed the six-year sentence of Mustafa Hassan Arif, who sold bogus drugs and health products under a panoply of brands he had concocted out of Pakistan.
By James Beck
The 21st Century Cures Act is noteworthy as the first legislative attempt at regulating artificial intelligence ("AI") in the medical field. The Act added this provision to the FDCA:
By Elizabeth Carder-Thompson, Debra McCurdy
The Centers for Medicare & Medicaid Services has confirmed that it expects to have a "temporary gap" in the DMEPOS competitive bidding program (CBP) during calendar years 2010-2020.
By Stephen J. McConnell
A federal judge in one of our non-drug or device cases recently informed the parties that he was so busy with his criminal docket that it might be better to let the magistrate judge take over our case, including trial.
By Kevin Madagan, Mildred Segura, Gerard Stegmaier, Maryanne C. Woo, Wendell Bartnick, Christopher M. Butler, David Krone
The Food and Drug Administration (FDA) published a draft update to its premarket cybersecurity guidance for device makers on October 18, 2018.
By Jillian Petrera, Jason Gordon
Last month, a class-action lawsuit was filed in federal court alleging that Kind, LLC ("Kind") deceptively advertises certain Kind bars and fruit packets.
Contributor's Topics